Bactiguard Holding AB (OSTO:BACTI B)
kr 35.3 -2.7 (-7.11%) Market Cap: 1.24 Bil Enterprise Value: 1.37 Bil PE Ratio: 0 PB Ratio: 4.06 GF Score: 60/100

Q3 2024 Bactiguard Holding AB Earnings Call Transcript

Oct 24, 2024 / 09:00AM GMT
Release Date Price: kr45 (+1.58%)
Christine Lind
Bactiguard Holding AB - Chief Executive Officer

Welcome to the presentation of Bactiguard Q3 2024 report. I will go through the presentation together with my colleague, Patrick Bach, our co and open up for questions towards the end. Thank you all for dialing in today.

Let's go straight into the overarching theme of the report. We are very pleased to announce profitability on an EBITA level both for the third quarter and year-to-date. This is a demonstration that our license focused strategy and business model that we embarked on late last year is working and effective.

As you know, we also had some disappointing news in early October after the end of the quarter when Zimmer Biomet terminated the agreement covering multiple orthopedic product segments.

The broad commercial potential in these segments was a key driver of our 2028 financial targets, considering this and to further take the opportunity for reflection after last year's transformation work, we have decided to initiate a review of our financial targets. The outcome will be communicated in Q1 2025.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot